Abstract:The recurrent pathogenic variant KCNC1-p.Ala421Val (A421V) is a cause of developmental and epileptic encephalopathy characterized by moderate-to-severe developmental delay/intellectual disability, and infantile-onset treatment-resistant epilepsy with multiple seizure types including myoclonic seizures. Yet, the mechanistic basis of disease is unclear. KCNC1 encodes Kv3.1, a voltage-gated potassium channel subunit that is highly and selectively expressed in neurons capable of generating action potentials at high frequency, including parvalbumin-positive fast-spiking GABAergic inhibitory interneurons in cerebral cortex (PV-INs) known to be important for cognitive function and plasticity as well as control of network excitation to prevent seizures. In this study, we generate a novel transgenic mouse model with conditional expression of the Ala421Val pathogenic missense variant (Kcnc1-A421V/+ mice) to explore the physiological mechanisms of KCNC1 developmental and epileptic encephalopathy. Our results indicate that global heterozygous expression of the A421V variant leads to epilepsy and premature lethality. We observe decreased PV-IN cell surface expression of Kv3.1 via immunohistochemistry, decreased voltage-gated potassium current density in PV-INs using outside-out nucleated macropatch recordings in brain slice, and profound impairments in the intrinsic excitability of cerebral cortex PV-INs but not excitatory neurons in current-clamp electrophysiology. In vivo two-photon calcium imaging revealed hypersynchronous discharges correlated with brief paroxysmal movements, subsequently shown to be myoclonic seizures on electroencephalography. We found alterations in PV-IN-mediated inhibitory neurotransmission in young adult but not juvenile Kcnc1-A421V/+ mice relative to wild-type controls. Together, these results establish the impact of the recurrent Kv3.1-A421V variant on neuronal excitability and synaptic physiology across development to drive network dysfunction underlying KCNC1 epileptic encephalopathy.

Lgi1 Null Mutant Mice Exhibit Myoclonic Seizures and Ca1 Neuronal Hyperexcitability

A Patient-Derived Mutation of Epilepsy-Linked LGI1 Increases Seizure Susceptibility Through Regulating Kv1.1.

A novel <i>Lgi1</i> mutation causes white matter abnormalities and impairs motor coordination in mice

LGI1 is Involved in the Development of Mouse Brain

14-3-3 proteins stabilize LGI1-ADAM22 levels to regulate seizure thresholds in mice

The LGI1 protein: molecular structure, physiological functions and disruption-related seizures

Novel Mouse Model of Alternating Hemiplegia of Childhood Exhibits Prominent Motor and Seizure Phenotypes

Na+ Channel Expression and Neuronal Function in the Na+/H+ Exchanger 1 Null Mutant Mouse.

Autosomal dominant lateral temporal epilepsy in a family exhibiting a rare heterozygous mutation and deletion in the leucine-rich glioma inactivated 1 gene

Na<sup>+</sup>Channel Expression and Neuronal Function in the Na<sup>+</sup>/H<sup>+</sup>Exchanger 1 Null Mutant Mouse

CRISPR/Cas9-mediated mutation of asparagine-linked glycosylation 13 transcript variant 1 causes epilepsy in mice

Essential roles of leucine-rich glioma inactivated 1 in the development of embryonic and postnatal cerebellum

Impaired excitability of fast-spiking neurons in a novel mouse model of epileptic encephalopathy

Mouse models of Slc35a2 brain mosaicism reveal mechanisms of mild malformations of cortical development with oligodendroglial hyperplasia in epilepsy

Impaired excitability of fast-spiking neurons in a novel mouse model of KCNC1 epileptic encephalopathy

Face-valid phenotypes in a mouse model of the most common mutation in EEF1A2 -related neurodevelopmental disorder

Functional characterization of a KCNAB3 genetic epilepsy with febrile seizures plus adult mouse model

CABP4 mutation in mice shows alteration in protein expression level and neuron discharge frequency

ADGRV1 is implicated in myoclonic epilepsy

Generation and Characterization of Three Novel Mouse Mutant Strains Susceptible to Audiogenic Seizures

GABAergic interneurons contribute to the fatal seizure phenotype of CLN2 disease mice